The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004
Open accessAbstract
Background Psoriasis is a predictor of morbidity. It is important to determine the extent to which psoriasis remains undiagnosed. Objective To determine the prevalence of psoriasis Methods Cross-sectional study using the National Health and Nutrition Exam Survey 2003–2004. Results The prevalence of diagnosed psoriasis was 3.15% (95% CI 2.18, 4.53), corresponding to 5 million adults. The prevalence of undiagnosed active psoriasis by conservative estimate was 0.4% (95% CI 0.19, 0.82) corresponding to approximately 600,000 US adults. Undiagnosed patients had a trend towards being more likely to be male, non white, less educated and unmarried compared to patients who had received a diagnosis. Limitations The method for determining the presence of psoriasis had limited ability to detect mild disease and only fair inter-rater agreement. Conclusion Over 5 million adults have been diagnosed with psoriasis. A large number have undiagnosed psoriasis and there are important disparities which may be associated with not receiving medical attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Self-citationPrevalence of cardiovascular risk factors in patients with psoriasis
Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.040 · Cited by 1,010
Self-citationStern, R. S., Nijsten, T., Feldman, S. R., Margolis, D. J., & Rolstad, T. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09102.x · Cited by 732
Prevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study
Gelfand, J. M., Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., & Margolis, D. J. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.12.1537 · Cited by 600
Self-citationEpidemiology of psoriatic arthritis in the population of the United States
Gelfand, J. M., Gladman, D. D., Mease, P. J., Smith, N., Margolis, D. J., Nijsten, T., Stern, R. S., Feldman, S. R., & Rolstad, T. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.03.046 · Cited by 596
Self-citationMartin, L. M., Leff, M., Calonge, N., Garrett, C., & Nelson, D. E. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(99)00158-0 · Cited by 587
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
Self-citationDeterminants of quality of life in patients with psoriasis: A study from the US population
Gelfand, J. M., Feldman, S. R., Stern, R. S., Thomas, J., Rolstad, T., & Margolis, D. J. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.014 · Cited by 367
Self-citationNaldi, L. (2004) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010043343958 · Cited by 320
The prevalence of psoriasis in African Americans: Results from a population-based study
Gelfand, J. M., Stern, R. S., Nijsten, T. E. C., Feldman, S. R., Thomas, J., Kist, J., Rolstad, T., & Margolis, D. J. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.07.045 · Cited by 310
Self-citationPsoriasis and metabolic disease: epidemiology and pathophysiology
Azfar, R. S., & Gelfand, J. M. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283031c99 · Cited by 297
Self-citationNEVITT, G. J., & HUTCHINSON, P. E. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1035.x · Cited by 281
Skin disease in Lambeth. A community study of prevalence and use of medical care.
Rea, J. N., Newhouse, M. L., & Halil, T. (1976) · Journal of Epidemiology & Community Health · doi:10.1136/jech.30.2.107 · Cited by 276
The Self-Administered Psoriasis Area and Severity Index Is Valid and Reliable
Feldman, S. R., Fleischer, A. B., Reboussin, D. M., Rapp, S. R., Lyn Exum, M., Clark, A. R., & Nurre, L. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329912 · Cited by 267
National Psoriasis Foundation Clinical Consensus on Disease Severity
Pariser, D. M., Bagel, J., Gelfand, J. M., Korman, N. J., Ritchlin, C. T., Strober, B. E., Van Voorhees, A. S., Young, M., Rittenberg, S., Lebwohl, M. G., et al. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.2.239 · Cited by 175
Self-citationThe prevalence of psoriasis in the Mongoloid race
Yip, S. Y. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80314-x · Cited by 153
Johnson, M. T., & Roberts, J. (1978) · PubMed · Cited by 147
The prevalence of psoriasis in Denmark
Brandrup, F., & Green, A. (1981) · Acta Dermato Venereologica · doi:10.2340/0001555561344346 · Cited by 127
Psoriasis: familial predisposition and environmental factors.
Kavli, G., Førde, O. H., Arnesen, E., & Stenvold, S. E. (1985) · BMJ · doi:10.1136/bmj.291.6501.999 · Cited by 121
Update on the epidemiology and systemic treatment of psoriasis
Kurd, S. K., Richardson, S. K., & Gelfand, J. M. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.2.171 · Cited by 31
Self-citationLong-term Treatment for Severe Psoriasis
Gelfand, J. M. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.9.1191 · Cited by 11
Self-citation
Cited by
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Parisi, R., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.339 · Cited by 2,592
A systematic review of worldwide epidemiology of psoriasis
Michalek, I. M., Loring, B., & John, S. M. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13854 · Cited by 1,150
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,145
Self-citationJoint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Menter, A., Strober, B. E., Kaplan, D. H., Kivelevitch, D., Prater, E. F., Stoff, B., Armstrong, A. W., Connor, C., Cordoro, K. M., Davis, D. M. R., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.057 · Cited by 969
Self-citationBrodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Metadata
- Authors
- Kurd, S. K., & Gelfand, J. M.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 60
- Issue
- 2
- Pages
- 218-224
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2087371579
- Cited by
- 519
- References
- 22
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.